Improving predictability and transparency in DEA and FDA regulation

Improving predictability and transparency in DEA and FDA regulation

hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 7, 2014

3/5
Впервые опубликовано
2015
Издатели
U.S. Government Publishing Office
Язык
English

Книги

Похожие книги